The Times Fast Track 100 is an annual league table compiled to form a comprehensive list of the UK’s most successful private companies in terms of outright growth. The basis for entry is two fold, firstly, the average of the last 3 years trading growth sales turnover is considered. Secondly, companies need to have made a profit in the previous trading year to be considered; therefore any companies who may not have a long-term future with their business model are weeded out.

Sales turnover is the primary measure of a company’s size based on how much it sells in any given 12 month period. Sales turnover does not have a direct relation to a company’s profit which is calculated once the cost of running the business has also been subtracted from the turnover.

Growth is important for a business from a number of perspectives, firstly, it shows that the business is healthy and using its working capital effectively, this means it is a better place to have money invested than in a bank which has only a 1% interest rate. Secondly, growth is a statement that a business has a bright future and that directly affects the value. A business where earnings are higher tomorrow than today means its shares will trade at a premium to the base profit level. Thirdly, it means that the company’s strategy is correct, a business which is growing quickly means that demand is high and therefore its products are working well.

The table is a method of comparing any one company’s growth success against any other. There are many thousands of companies operating in the United Kingdom and to be amongst the 100 fastest growing is a testament to the businesses current strategy and future ambitions.

This is the first year Alliance Surgical plc has been able to enter the table as such a young business. It is important to state that this table justifies the support the shareholders have given in getting the business to this level – however, this is only the start. The company is focused entirely on building a successful long term organization which will net shareholders valuable dividends whilst building capital value. The business continues to aim to grow as quickly and efficiently as possible to build value for the highly committed shareholders of the company.

The company would like to take this opportunity to thank its 450 consultant surgeon shareholders for their help, dedication and support in its’ early years of trading.